An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

Katherine M E Turner; Jeff A Round; Paddy J Horner; John A A Macleod; Simon Goldenberg; Arminder Deol; Elisabeth J Adams

doi:10.1136/sextrans-2013-051147

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

Katherine M E Turner
, Jeff A Round
, Paddy J Horner
, John A A Macleod
, Simon Goldenberg
, Arminder Deol
, Elisabeth J Adams

Research output: Contribution to journal › Article (Academic Journal) › peer-review

70 Citations (Scopus)

Abstract

To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.

Original language	English
Pages (from-to)	104-111
Number of pages	8
Journal	Sexually Transmitted Infections
Volume	90
Issue number	2
DOIs	https://doi.org/10.1136/sextrans-2013-051147
Publication status	E-pub ahead of print - 22 Nov 2013

Access to Document

10.1136/sextrans-2013-051147

Handle.net

Persistent link

Cite this

Turner, K. M. E., Round, J. A., Horner, P. J., Macleod, J. A. A., Goldenberg, S., Deol, A., & Adams, E. J. (2013). An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sexually Transmitted Infections, 90(2), 104-111. Advance online publication. https://doi.org/10.1136/sextrans-2013-051147

@article{46e1fe3adf054dd48ee75c7cd654aa58,

title = "An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England",

abstract = "To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.",

author = "Turner, \{Katherine M E\} and Round, \{Jeff A\} and Horner, \{Paddy J\} and Macleod, \{John A A\} and Simon Goldenberg and Arminder Deol and Adams, \{Elisabeth J\}",

year = "2013",

month = nov,

day = "22",

doi = "10.1136/sextrans-2013-051147",

language = "English",

volume = "90",

pages = "104--111",

journal = "Sexually Transmitted Infections",

issn = "1368-4973",

publisher = "BMJ Publishing Group",

number = "2",

}

Turner, KME, Round, JA, Horner, PJ, Macleod, JAA, Goldenberg, S, Deol, A & Adams, EJ 2013, 'An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England', Sexually Transmitted Infections, vol. 90, no. 2, pp. 104-111. https://doi.org/10.1136/sextrans-2013-051147

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. / Turner, Katherine M E; Round, Jeff A; Horner, Paddy J et al.
In: Sexually Transmitted Infections, Vol. 90, No. 2, 22.11.2013, p. 104-111.

Research output: Contribution to journal › Article (Academic Journal) › peer-review

TY - JOUR

T1 - An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

AU - Turner, Katherine M E

AU - Round, Jeff A

AU - Horner, Paddy J

AU - Macleod, John A A

AU - Goldenberg, Simon

AU - Deol, Arminder

AU - Adams, Elisabeth J

PY - 2013/11/22

Y1 - 2013/11/22

N2 - To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.

AB - To estimate the costs and benefits of clinical pathways incorporating a point of care (POC) nucleic acid amplification test (NAAT) for chlamydia and gonorrhoea in genitourinary medicine (GUM) clinics compared with standard off-site laboratory testing.

U2 - 10.1136/sextrans-2013-051147

DO - 10.1136/sextrans-2013-051147

M3 - Article (Academic Journal)

C2 - 24273127

SN - 1368-4973

VL - 90

SP - 104

EP - 111

JO - Sexually Transmitted Infections

JF - Sexually Transmitted Infections

IS - 2

ER -

Turner KME, Round JA, Horner PJ, Macleod JAA, Goldenberg S, Deol A et al. An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England. Sexually Transmitted Infections. 2013 Nov 22;90(2):104-111. Epub 2013 Nov 22. doi: 10.1136/sextrans-2013-051147

An early evaluation of clinical and economic costs and benefits of implementing point of care NAAT tests for Chlamydia trachomatis and Neisseria gonorrhoea in genitourinary medicine clinics in England

Abstract

Access to Document

Handle.net

Fingerprint

Cite this